Skip to main content

The Role of Pseudotype Neutralisation Assays in Understanding SARS CoV-2

Cantoni, Diego, Mayora-Neto, Martin, Temperton, Nigel J. (2021) The Role of Pseudotype Neutralisation Assays in Understanding SARS CoV-2. Oxford Open Immunology, . Article Number iqab005. E-ISSN 2633-6960. (doi:10.1093/oxfimm/iqab005) (KAR id:86594)

PDF Author's Accepted Manuscript
Language: English

Click to download this file (221kB) Preview
[thumbnail of iqab005.pdf]
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL:


Neutralisation assays are crucial tools to quantify the presence of functional neutralising antibodies in serum samples. Since the SARS-CoV-2 virus (the causative agent of COVID-19) is designated as a category 3 biosafety level pathogen, pseudotyped viruses bearing the SARS-CoV-2 spike protein permit extensive and widespread serum/plasma screening in a BSL 2 laboratory. These assays can be used to assess viral tropism, vaccine immunogenicity, efficacy of antiviral compounds (incl. therapeutic mAbs) and serosurveillance studies. In this article, we highlight approaches to SARS-CoV-2 viral pseudotyping, its practicality, and utility in increasing our understanding of neutralising antibodies against SARS-CoV-2.

Item Type: Article
DOI/Identification number: 10.1093/oxfimm/iqab005
Uncontrolled keywords: COVID-19, SARS CoV-2, neutralisation assays
Subjects: Q Science > QR Microbiology > QR355 Virology
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Nigel Temperton
Date Deposited: 14 Feb 2021 16:10 UTC
Last Modified: 14 Jan 2022 16:58 UTC
Resource URI: (The current URI for this page, for reference purposes)
Temperton, Nigel J.:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.